BENEFITS OF ACTOS - PIOGLITAZONE FOR TYPE 2 DIABETES UNCLEAR
                   
mediconews.com     Jul 25, 2008          

Diabetes :: Benefits of Actos - pioglitazone for intend 2 diabetes unclear According to a analyse of clinical trials, benefits of pioglitazone for intend 2 diabetes is unclear. Marketed by Takeda Pharmaceuticals and Eli Lilly & Co. as Actos, pioglitazone belongs to a collection of drugs titled thiazolidinediones that impact by crescendo the body’s sense to insulin, to meliorate curb patients’ murder sugar. It is utilised lonely or in compounding with another drugs if diabetes can’t be dominated by fasting and exercise. After evaluating publicised technological studies in which patients with intend 2 diabetes were aerated with pioglitazone, there was no “convincing evidence” that the take low mortality, rate or inauspicious effects, or positively influenced health-related calibre of life, advance communicator Dr. Bernd... [read full story]                    


View all news articles about*:
Aid Anti-diabetic Care Diabetes Diet Drugs Eli Health Lilly Medicines Metabolic Patients Pharmaceuticals Problems Remedies Takeda
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

PDL Could Get $1.2B from BMS for Two Early Stage Antibodies

tmcnet.com     17 hrs ago   14 related          

710M for Elotuzumab After struggling through a year of shifting business strategies, PDL BioPharma Inc. signed an antibody deal with Bristol-Myers Squibb Co. that could be worth nearly $1.16 billion. The deal calls for New...                    

comments

Biotech buyout action likely to continue

ibtimes.com     21 hrs ago   4 related          

NEW YORK - A buyout bull's-eye will likely remain on biotechnology companies over the next few years as major pharmaceutical companies continue taking advantage of a weak dollar and a surplus of cash to buy pipeline additions....                    

comments

                   

FDA reports deaths with diabetes drug Byetta

usatoday.com     Aug 19, 2008   149 related          

Fast facts about diabetes in the USA: People with diabetes: 24.1 million People with pre-diabetes: about 56 million The cost of diabetes in the USA: $174 billion a year Source: Centers for Disease Control and Prevention No....                    

comments

                   

Affymax(R) Reports Second Quarter 2008 Financial Results (Business Wire)

yahoo.com     Aug 18, 2008   7 related          

PALO ALTO, Calif.----Affymax, Inc. today reported financial results for the second quarter ended June 30, 2008. The net loss for the second quarter of 2008 was $18.9 million compared to a net loss of $9.2 million for the second...                    

comments